Obata K, Hoshiai H
Department of Obstetrics and Gynecology, Kinki University School of Medicine, Osaka-Sayama, Japan.
Gynecol Obstet Invest. 2000;50 Suppl 1:39-43. doi: 10.1159/000052877.
We analyzed 81 ovarian cancers for loss of heterozygosity (LOH) on 10q23 and for mutations in PTEN. LOH was common among the endometrioid (43%) and serous (28%) cancers, but was infrequent among the other histological subtypes. Somatic PTEN mutations were detected in seven (21%) endometrioid cancers and the mutation in all informative cases was accompanied by loss of the wild-type allele. One mucinous cancer without 10q23 LOH was shown to harbor two somatic PTEN mutations. Frequent LOH was observed on chromosome 6q (60.0%) and chromosome 10q (40.0%) in ovarian atypical endometriosis, but no PTEN mutations were observed. These findings support the hypothesis that endometrioid and clear cell ovarian carcinomas may arise through malignant transformation of endometriotic lesions.
我们分析了81例卵巢癌,以检测10q23上的杂合性缺失(LOH)以及PTEN的突变情况。LOH在子宫内膜样癌(43%)和浆液性癌(28%)中较为常见,但在其他组织学亚型中则较少见。在7例(21%)子宫内膜样癌中检测到体细胞PTEN突变,且在所有信息充分的病例中,突变均伴有野生型等位基因的缺失。1例无10q23 LOH的黏液性癌被发现存在两个体细胞PTEN突变。在卵巢非典型子宫内膜异位症中,6号染色体(60.0%)和10号染色体(40.0%)上常出现LOH,但未观察到PTEN突变。这些发现支持了子宫内膜样和透明细胞卵巢癌可能通过子宫内膜异位病变的恶性转化而发生的假说。